Better Together: Examples of Biostatisticians Collaborating in Drug Development

Russell Reeve (), Seth Berry and Brandon Swift
Additional contact information
Russell Reeve: IQVIA
Seth Berry: IQVIA
Brandon Swift: Metvant Sciences

Chapter Chapter 9 in Quantitative Methods in Pharmaceutical Research and Development, 2020, pp 409-445 from Springer

Abstract: Abstract Collaboration between biostatisticians, pharmacokineticists, clinicians, formulation, and laboratory scientists provides a wealthy pool of specialty experience to draw from. When working as a team, using quantitative modeling and simulation methodologies, significant efficiencies, and improvements can be made in the drug development process. The following chapter illustrates several case studies illustrating the impact these close collaborations can foster.

Keywords: Biosimilar; Assay; Simulation; Response surface design; Software as a medical device (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-030-48555-9_9

Ordering information: This item can be ordered from
http://www.springer.com/9783030485559

DOI: 10.1007/978-3-030-48555-9_9

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().